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INTRODUCTION
Clinical pharmacy is defined as “a health science discipline in which pharmacists provide patient care that optimizes 
medication therapy and promotes health, wellness, and disease 
prevention” and “embraces the philosophy of pharmaceutical care.”1
The role of the clinical pharmacist is to promote safe, effective, and
cost-conscious drug therapy and improve patient outcomes.2
Published evidence from observational studies, randomized
controlled trials, and systematic reviews has shown that clinical
pharmacist activities improve patient, medication, and surrogate
outcomes; reduce health resource utilization and costs; reduce
morbidity and mortality; and improve patients’ quality of life.3-6
Despite published evidence supporting the benefits of clinical
pharmacy services for health and economic outcomes, quantitative
expressions that describe whether or how often a process of care
or outcome of care occurs, also known as performance indicators,
must be monitored to ensure that these services are delivered 
consistently. However, until recently, there was no established
consensus as to which activities are key indicators of clinical 
pharmacy performance. A grass-roots collaborative of Canadian
hospital pharmacists recently addressed this unanswered question
by systematically establishing clinical pharmacy key performance
indicators (cpKPIs) using a Delphi technique.7 Some questions
remain, including “What activities do pharmacists perform, and
how consistently do they perform them?” To answer these 
questions, we first must understand what cpKPIs are; why
cpKPIs should be measured and reported; who will be affected
by these measurements; where and how cpKPIs can be measured,
reported, and utilized: and when we should begin to capture 
cpKPIs. This article aims to address these questions about cpKPI
adoption and measurement from multiple perspectives (including
those of front-line pharmacists, leadership, external stakeholders,
and the public), supplemented by examples from the authors’ 
experience. 
WHAT ARE cpKPIs? 
Key performance indicators are quantifiable measures of
quality that can be used to track an organization’s progress toward
achieving intended goals related to process inputs, process 
outputs, or outcomes.8 These indicators are discrete events that,
when they occur for an individual patient, have been proven to
result in a positive outcome for that person. The US Agency for
Healthcare Research and Quality (AHRQ) defines a process
measure as “a health care-related activity performed for, on behalf
of, or by a patient” and assesses the activities carried out by health
care professionals to deliver services.9 These types of measures are
most useful when there is strong evidence associating processes
with clinically important outcomes. The AHRQ defines an 
outcome measure as “a health state of a patient resulting from
health care”, noting that such measures can encompass a 
vast range of health states, including physiologic measurements,
laboratory test results, or a patient’s symptoms, morbidity, 
functional state, and quality of life.10 Many “outcome measures”
actually employ processes of care or use of services (e.g., hospital
readmission rates) as “proxies” for patients’ health states. Key 
performance indicators differ from workload measurement or
workload management because they are selected on the basis of
a proven association with a positive patient outcome, whereas
workload measurement or management counts the frequency 
of an activity that is not necessarily specifically known to affect 
outcomes for individual patients. Moreover, a cpKPI would be
selected only if the specific activity or event had been proven to
have a positive effect on patient outcome.
Fernandes and others7 indicated that a cpKPI should fulfill
the following criteria: reflect a desired quality of practice, link to
direct patient care, be supported by evidence of an impact on
meaningful patient outcomes, be pharmacy- or pharmacist-
sensitive, and be feasible to measure. The Delphi rounds resulted
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in identification of 8 cpKPIs (Table 1), which fell into 6 clinical
pharmacy critical activity areas: admission medication reconcili-
ation, interprofessional patient care rounds, pharmaceutical care,
discharge medication reconciliation, patient education or 
discharge counselling, and bundled critical activity areas.7
WHY CAPTURE cpKPIs?
The Canadian consensus cpKPIs were developed to support
improvement in the quality of patient care and to advance 
evidence-informed clinical pharmacy practice. They can help to
delineate the patient care expectations of a clinical pharmacist,
describe standards of practice, permit benchmarking within and
between organizations, and elevate professional accountability
and transparency.7 The collaborative of Canadian hospital 
pharmacists (now becoming known as the Canadian National
cpKPI Collaborative), with its strong stake in clinical pharmacy
practice, overwhelmingly agreed that measuring the 8 consensus
cpKPIs would be useful in advancing clinical pharmacy practice
and improving the quality of patient care. Validation of the 
importance of cpKPIs came from nonpharmacist stakeholders
who agreed or strongly agreed that measuring the 8 national 
cpKPIs would be useful in advancing clinical pharmacy practice
and improving the quality of patient care.11
Focusing on activities that have been shown to decrease
morbidity and hospital readmission increases the likelihood that
a pharmacist’s work will contribute to positive patient outcomes.
The cpKPIs can provide practical guidance to assist in prioritizing
a pharmacist’s work and articulating patient care expectations.
Front-line pharmacists and pharmacy leaders can collaboratively
use cpKPIs as tools for self-reflection and for identifying improve-
ment opportunities to advance practice. For example, at the Nova
Scotia Health Authority—Central Zone, cpKPI data are shared
among clinical pharmacy team members to generate discussion
and inspire creative solutions to prioritize tasks, streamline 
workflow, and avoid redundancy. Examples of the successful use
of cpKPIs include liaising with charge nurses to capture 
opportunities for discharge medication reconciliation and 
creating a handover mechanism for pharmacists taking over care
of a service, to avoid duplication. 
Pharmacy leaders and hospital administrators are charged
with ensuring that pharmacists provide the best care for patients
within a given budget, thus supporting the effective use of health
care resources. In some organizations, cpKPI data have been 
presented to quality committees, senior management, and
boards. For example, at the Regina Qu’Appelle Health Region
and the Vancouver Island Health Authority, data are shared with
senior management to demonstrate the value of pharmacists in
diverse areas. Capturing the resolution of drug therapy problems
(DTPs) that involve high-alert drugs (as defined by the US 
Institute for Safe Medication Practices) has helped to demon-
strate the impact of pharmacists on medication and patient safety.
At the University Health Network in Toronto, Ontario, cpKPIs
form part of the organization’s balanced scorecard. 
Demonstrating the value of clinical pharmacy services
within business plans has become increasingly important as
health authorities are required to make difficult choices about 
resource allocation to optimize patient care. By capturing the
value of clinical pharmacy services through measurement of 
cpKPIs, administrators and managers have access to data that
may support maintaining or expanding clinical pharmacy services
to provide appropriate evidence-based care. For example, at the
Interior Health Authority in British Columbia, pharmacist 
positions have been created on the basis of cpKPI data to justify
pharmacy services. In defending pharmacy resources during 
periods of financial stress, cpKPI data can serve as a powerful tool
for maintaining pharmacy services. Recently, with support from
cpKPI data, leaders of the Regina Qu’Appelle Health Region
were successful in protecting pharmacist positions against budget
restraint measures. 
Pharmacy managers may use cpKPI data to evaluate and 
enhance patient care activities. Process measurement, such as
counting the number of patients who have received specific
Table 1. The 8 National Clinical Pharmacy Key Performance Indicators (cpKPIs)7
cpKPI                                                                                                                                  Description
Medication reconciliation on admission     Proportion of patients who receive documented admission medication reconciliation 
                                                                 (as well as resolution of identified discrepancies) performed by a pharmacist
Pharmaceutical care plan                           Proportion of patients for whom pharmacists have developed/initiated a pharmaceutical 
                                                                 care plan
Drug therapy problems                              Number of drug therapy problems addressed by a pharmacist per admission
Interprofessional patient care rounds         Proportion of patients for whom pharmacists participate in interprofessional patient care 
                                                                 rounds to improve medication management
Patient education during hospital stay       Proportion of patients who receive education from a pharmacist about their disease(s) 
                                                                 and medications(s) during their hospital stay
Patient education at discharge                  Proportion of patients who receive medication education by a pharmacist at discharge
Medication reconciliation at discharge       Proportion of patients who receive documented discharge medication reconciliation and 
                                                                 resolution of identified discrepancies by a pharmacist
Bundled patient care interventions            Proportion of patients who receive comprehensive direct patient care from a pharmacist 
                                                                 working in collaboration with the health care team
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cpKPI activities in relation to the total number of patients, can
elevate the professional accountability of pharmacists and provide
recognition for their work. Adopters of measurement programs
in health care have witnessed improvement in performance over
time.12 At the Interior Health Authority, pharmacists capture 
3 aspects of a resolved DTP: disease state, drug, and intervention.
Feedback based on the captured aggregate data across the 
organization is given to all clinical pharmacists, as a group, to 
encourage practice toward resolving DTPs that are predefined as
reflecting the highest-quality evidence-based pharmacotherapy
interventions, such as adding an angiotensin-converting enzyme
inhibitor for a patient with heart failure in the absence of 
contraindications. Nonetheless, cpKPIs represent only one type
of indicator on the performance dashboard, and there are many
components of a pharmacist’s work that these indicators do not
capture.
The publicly funded health care system is increasingly 
required to be accountable for the value it provides. Across
Canada, the provinces allocate, on average, about 38 cents of
every budgeted dollar toward health care.13 A recent newspaper
article stated that $3.6 billion was spent to fund 10 000 phys -
icians in 2011/2012, with no mechanism on the government’s
part to ensure that physician services are achieving value for
money.14 The same scrutiny should be imposed on pharmacists
in the future as budget pressures continue to escalate. Data for
cpKPIs may be useful metrics to better inform taxpayers and 
external stakeholders on the value of pharmacists to patient care. 
WHO IS AFFECTED BY cpKPIs? 
The ultimate goal of cpKPI measurement and reporting is
to advance clinical pharmacy practice and thus to improve the
quality of patient care. Patients are affected by the care they 
receive from pharmacists who deliver high-value activities proven
to optimize outcomes. Targeting a consistent suite of cpKPIs may
result in the establishment of expectations of pharmacist services
for patients and the health care team. Front-line pharmacists are
tasked with providing and documenting their care in collabora-
tion with other care team members. Measuring and reporting
cpKPIs will also affect other stakeholders, including pharmacy
leadership, interprofessional team members, and nonpharmacy
administrators. Pharmacy leadership analyzes and evaluates the
cpKPI data generated to better understand the gaps in knowledge
and skills of their pharmacists in order to support their profes-
sional development.
WHERE ARE cpKPIs BEING CAPTURED? 
Some sites, such as the Regina Qu’Appelle Health Region
in Saskatchewan and the University Health Network in Toronto,
started capturing select cpKPIs over a decade ago, and other sites
are now beginning to collect designated indicators. These more
recent adopters include the Vancouver Island Health Authority
and the Interior Health Authority in British Columbia, as well
as the Nova Scotia Health Authority—Central Zone. Along with
site-specific data capture, the Canadian National cpKPI Collab-
orative has begun initial groundwork for the development of a
national registry of Canadian cpKPIs, to facilitate data collection
at individual sites and analysis at the local level and then more
broadly using a comparative national analysis. 
At the University Health Network, for example, a clinical
metrics “cross-walk” document was developed through live focus
groups, during which front-line pharmacists summarized their
opinions about desired attributes for a cpKPI-capture system.
“Easy to use and intuitive” was voted by most sites as an impor-
tant attribute for success in capturing these data. For example,
building tracking into existing electronic patient care systems,
designing a data-entry interface with tick box predominance, and
auto-populating fields are features that achieve ease of use. 
The authors of the current article conducted semistructured 
interviews with Canadian pharmacy leaders known to be 
involved in cpKPI, which showed that various cpKPI collection
strategies are currently in place, including paper-based collection,
hospital-wide electronic health records, Microsoft Access 
databases (Microsoft; https://products.office.com/en-ca/access),
HanDBase software (DDH Software Inc; www.ddhsoftware.com/
handbase.html), Emerald Health Information Systems
(www.emeraldhis.com/), and Google Forms (https:// www.google.
ca/forms/about). Examples of cpKPIs that are tracked nationally
by these organizations are described in Table 2.
At sites with established clinical intervention tracking 
programs, a shift to collecting cpKPI may be less of a challenge
than at sites that do not currently track pharmacist clinical 
interventions on a routine basis. Barriers and proposed solutions,
based on the current authors’ experiences, are summarized in
Table 3. 
Front-line pharmacists may not routinely track clinical 
metrics; therefore, an implementation challenge arises when these
pharmacists do not see the authentic, multidimensional value of
capturing cpKPIs and instead perceive their integration as a 
top–down mandate. Most pharmacists are inspired by influential
patient care enhancements. As such, reiterating how performing
cpKPI activities has been shown to positively influence morbidity
and readmission is important. Harmonizing cpKPIs with local
and health region priorities, Accreditation Canada, and CSHP
2015 paints the “big picture” and helps to align priorities. 
Rather than convincing front-line staff to “buy in” to 
pre-set ideas, leaders can actively seek the support of pharmacists
by instilling an authentic sense of “ownership” and involving staff
members in meaningful cpKPI decision-making. Pharmacists
value the efficiency of a system that captures data in a fashion
that minimizes time taken away from patient care. The University
Health Network and the Nova Scotia Health Authority—Central
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Zone are examples of organizations where cpKPIs were rolled out
through a grass-roots movement championed by inspired (and
inspiring) front-line pharmacists. Such active leadership by front-
line staff can enhance momentum and acceptance for cpKPI 
capture among peer pharmacists. 
WHAT ARE THE BENEFITS 
OF CAPTURING cpKPIs? 
The Interior Health Authority has used trend analysis to
provide insight into processes over time. Unpublished data 
collected between 2009 and 2014 were used to define strategies
pertaining to pharmacists’ deployment to care areas. These data
showed that pharmacists who were integrated into care teams
were more effective than pharmacists who performed trouble-
shooting on multiple wards. Within the data, it was apparent
that the majority of resolved DTPs had occurred at tertiary care
centres, rather than rural centres. These data are useful for 
ensuring that pharmacist resources are aligned to generate the
greatest clinical impact. Finally, the data are useful in perform-
ance evaluation, as they allow discussion of personalized trends
in resolved DTPs over time, rather than an absolute number or
quota. 
One of the goals of capturing cpKPIs, especially in a national
database, is to standardize, advance, and benchmark (internally
and externally) clinical pharmacy practice. By developing 
comparison strategies, we can share and learn best practices and
advance the profession. A challenge in setting benchmarks is 
deciding on the appropriate denominator. 
Translating the cpKPI data into information that is useful
to the public and external stakeholders is critical. For example,
Mourao and others11 found in their stakeholder feedback study
that discharge medication reconciliation was the cpKPI most
likely to influence decisions to fund or use clinical pharmacist
services among nonpatient stakeholders. Several approaches have
been taken by health authorities to assist external stakeholders in
understanding cpKPI data:
• Evidence-based extrapolation: An extrapolation was 
performed by the Interior Health Authority on the basis of
RCT data5,6 (see Table 4). The organization’s press release
for Pharmacy Day 201416-18 presented cumulative data for
resolved DTPs and explained how the data translated into
reductions in emergency room visits, drug-related readmis-
sions, and overall system costs.
• Real-life correlation: In an observational cohort study, the
University Health Network tracked outcomes for 8678 
patients who received a select cpKPI-based intervention on
one internal medicine ward over 5 years. With adjustment
through propensity analysis in this small pilot study, the 
organization detected a nonsignificant trend (reduction in
30-day hospital visits and readmissions by 2%) that can be
explored more comprehensively in larger studies.19 Convert-
ing abstract cpKPI data into tangible outcomes (such as 
hospital readmissions averted and monetary worth) helps
the public, as well as nonpharmacist senior management, to
appreciate the value contributed by clinical pharmacists.
• Heat matrix: For each resolved DTP, pharmacists at the 
Vancouver Island Health Authority estimate the clinical 
Table 2. Sample of cpKPIs Currently Being Captured across Canada
cpKPI Captured                                       Vancouver Island       Interior Health          Qu’Appelle         University Health       Nova Scotia
                                                                 Health Authority           Authority           Health Region              Network                   Health
                                                                            (BC)                            (BC)                         (SK)                           (ON)                Authority (NS)
Medication reconciliation                               √                          √ *                        √                             √                           √
on admission
Pharmaceutical care plan                                                            √ *                                                    √ †                        √
Drug therapy problem                                    √                             √                           √                                                          √
Disease                                                                                       √                           √
Drug                                                            √                             √                           √                              
Type                                                             √                             √                           √
Significance and likelihood                         √
of future event                                             
Interprofessional patient care rounds                √                          √ *                        √                          √ †                        √
Patient education during hospital stay               √                          √ *                        √                          √ †                        √
Patient education at discharge                        √                          √ *                                                    √ †                        √
Medication reconciliation at discharge              √                          √ *                                                       √                           √
Bundled patient care interventions                                              √ *                                                    √ †                        √
Data-capture software                             Microsoft               HanDBase          Google Forms         Hospital-wide       Emerald Health
                                                           Access database                                                                       electronic            Information
                                                                                                                                                        health record             Systems
Users of data                                                 F, S                        F, S, E                      F, S                        F, S, E                      F, S
BC = British Columbia, cpKPI = clinical pharmacy key performance indicators, E = external stakeholders (patients/public), 
F = front-line pharmacist, NS = Nova Scotia, ON = Ontario, S = senior management, SK = Saskatchewan.
*Completed as part of a research project; not continuously captured. 
†Selected sites at this location.
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Table 3. Purposes, Challenges, and Solutions of Implementing Clinical Pharmacy Key Performance 
Indicators (cpKPIs)
Rationale and Utility of cpKPIs                                          Barriers and Challenges                         Authors’ Proposed Solutions
Front-line pharmacists
Provide reference summary of:                                 Time required to                      • Automate data collection where possible (e.g.,
• Activities proven to improve outcomes                  document cpKPIs                     self-populated patient name and medical record
• Priority of patient care activities to optimize                                                          number) 
impact on outcomes                                                                                              • Enable pull-down data entry at point of care 
• Pharmacists’ role that can be promoted to other                                                  • Incorporate into electronic health care system
members of interdisciplinary team                         Complexity of indicator           • Simplify platform for documentation;
• Performance expectations with the employer       documentation                        e.g., check boxes
                                                                                                                                • Collect minimal amount of required information
                                                                                Cost                                         • Use existing or least expensive hardware and 
                                                                                                                                software data platforms 
                                                                                Daily tracking and                   • Make it a daily routine for all pharmacists
                                                                                reporting consistency               • Pharmacist-to-pharmacist accountability
                                                                                                                                • Live capture or end-of-day input
Practice leaders and pharmacy managers
Provide reference summary for:                                Front-line staff ownership        • Access and use cpKPI knowledge mobilization kit*
• Justifying prioritization of scarce clinical                and uptake                              • Regularly present collected data to staff
pharmacy services                                                                                                  • Engage front-line staff in change management 
• Justifying expansion of clinical pharmacy services                                                  and leadership processes
• Explaining value and estimating return on            Lack of accuracy                      • Provide training during orientation and
investment in clinical pharmacy services                and precision                           interim audits
• Determining effectiveness and efficiency of                                                          • Facilitate understanding to resolve local
clinical pharmacy services                                                                                      apprehension
• Setting benchmarks                                              Effective change management • Change management strategies
• Performance management                                    to implement and sustain        
                                                                                cpKPIs with everyday practice  
                                                                                Trend analysis                           • Set benchmarks through comparison between
                                                                                                                                clinical wards, hospitals, or health regions
                                                                                                                                • Be cautious in analyzing trends
Patient, taxpayers, external stakeholders
Provide reference summary of:                                 Comprehension and                • Correlate with and extrapolate to meaningful
• Clinical pharmacists’ role                                       interpretation of cpKPI data     patient outcomes (e.g., hospital readmissions),
• Activities proven to improve patient outcomes                                                      with recognized limitations
• Patient expectations                                                                                              • Explain the clinical significance of cpKPIs
• Activities to ensure pharmacist accountability                                                        • Tailor presentation according to the interest
• Appropriate use of resources to promote a more                                                  of audience 
sustainable health care system                                                                              • Acknowledge limitations of reporting isolated
                                                                                                                              indicators versus a dashboard of indicators
                                                                                                                                • Acknowledge differences in systems and human 
                                                                                                                                resources across heterogeneous sites
*This kit is now available at www.cshp.ca/productsServices/cpKPI/index_e.asp
Table 4. Evidence-Based Extrapolation Performed by the Interior Health Authority, 
British Columbia15
Outcome                                                                               Relative Reduction*                 Annual Event 
                                                                                                                                               Reduction Rate†
Reduction in visits to emergency department                           47%                           19 177/year
Reduction in hospital visits                                                        16%                           21 804/year
Reduction in drug-related readmissions                                    80%                           15 689/year
Reduction in readmissions                                                         20%                            2 506/year
Estimated cost saving                                                         $230/patient                      $19 million
*Based on data from randomized controlled trials.5,6
†Based on 15 5701 drug therapy problems resolved from January 1, 2009, to December 31, 2014. 
The ratio extrapolation assumes a similar number of drug therapy problems resolved per patient, 
and similar direct and indirect costs from original trials.
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significance of the potential adverse outcome associated with
the problem and the likelihood of that outcome occurring
had there not been an intervention. This “heat map” 
provides a visual representation of the risk to patients that
has been averted as a consequence of clinical pharmacy 
services (Figure 1). This approach was adapted from the
Hazard Scoring Matrix promoted by the Institute for Safe
Medication Practices.22
• Tailor to your audience: Pharmacists may more effectively
deliver their message by tailoring key information in their 
presentations to the interest most valued by their specific 
audience. 
WHEN SHOULD WE START CAPTURING 
cpKPIs?
With the publication of a nationally agreed upon group of
cpKPIs, it is appropriate to start capturing these indicators across
Canada now. 
CONCLUSION
With the recent publication of systematically developed 
consensus cpKPIs, a nationwide database capturing cpKPIs from
multiple institutions may be feasible in the foreseeable future.
Implementing, measuring, and reporting cpKPIs will have many
advantages. For pharmacists, a defined list of cpKPIs can serve
as a basis for prioritizing patient care activities. For leadership,
cpKPI data can be used to demonstrate practitioner value, can
provide metrics for evaluating improvement initiatives, and can
inform performance evaluation. For patients, information 
on cpKPI measurements can demonstrate accountability and 
illustrate the impact of pharmacists on patient care. As a whole,
cpKPIs contribute to improved patient care and advance the 
profession of hospital pharmacy. In time, consensus cpKPIs can
be developed for primary care and community-based practices.
The time to capture cpKPIs is now!
Figure 1. “Heat matrix” from the Vancouver Island Health Authority for the period April 1 to October 1, 2015. Data values 
represent numbers of resolved drug therapy problems (DTPs) in each risk category, where the risk categories are defined by 
estimates of the clinical significance of the potential adverse outcomes and the likelihood of those outcomes occurring had
there not been an intervention. “No significance” means that the DTP had no clinical importance for the patient. “Minor 
significance” means that the DTP was of little clinical importance for the patient; small adjustments to therapy were required
but were not expected to significantly alter hospital stay, resource utilization, or clinical outcome. “Moderate significance”
means that the DTP required intervention leading to moderate benefit for the patient; adjustments to therapy were expected 
to enhance the effectiveness of drug therapy, producing minor reductions in patient morbidity or treatment costs. “Major 
significance” means that the DTP required an intervention to prevent a moderate to major or reversible detrimental effect or 
the DTP required an adjustment of therapy on the basis of accepted evidence-based guidelines. “Extremely significant” 
means that the DTP required an intervention to save the patient’s life or to prevent severe or irreversible detrimental effects. 
The aforementioned significance criteria were adapted from Kumar and others20 and Blix.21
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